24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease

NCT01316900 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

846

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: GSK573719/GW642444 125/25
DRUG: GSK573719/GW642444 62.5/25
DRUG: GW642444
DRUG: tiotropium bromide

Sponsor

GlaxoSmithKline